UPDATE - Media Advisory - Minister Philpott to visit Winnipeg and make announcements regarding First Nations education and health transformation
The location has been updated
WINNIPEG, Sept. 5, 2018 /CNW/ - Please be advised that the Honourable Jane Philpott, Minister of Indigenous Services will be in Winnipeg on Thursday, September 6, 2018, and will participate in two announcements.
In the morning, Minister Philpott will attend the grand opening of the expanded campus of Southeast Collegiate in Winnipeg, a secondary school that welcomes First Nations students from communities across Manitoba.
Following this event, Minister Philpott will make an important funding announcement for regional First Nations-led health transformation alongside Manitoba Keewatinowi Okimakanak (MKO).
The Minister will be available after each event to respond to questions from the media.
Southeast Collegiate Grand Opening Date: September 6, 2018 Time: 10:30 a.m. (CDT) Where: Southeast Collegiate 1269 Lee Blvd., Winnipeg, MB R3T 5W8
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...
